BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Bpc 157 and TB 500 My protocol and results explained! I've talked about this with probably a dozen different guys over the last 4 months so hopefully this helps someone else. #progress # The Complete Peptide Guide: Reconstitution, Injection & Storage Extension Health Liraglutide Dosage Chart Olympia Pharmaceuticals